A Brief Overview of Really Current Research on Dividends Gretchen A. Fix Department of Statistics Rice University 6 November 2003.

Slides:



Advertisements
Similar presentations
The analysis of survival data in nephrology. Basic concepts and methods of Cox regression Paul C. van Dijk 1-2, Kitty J. Jager 1, Aeilko H. Zwinderman.
Advertisements

Survival Analysis. Key variable = time until some event time from treatment to death time for a fracture to heal time from surgery to relapse.
Inferential Statistics and t - tests
If we use a logistic model, we do not have the problem of suggesting risks greater than 1 or less than 0 for some values of X: E[1{outcome = 1} ] = exp(a+bX)/
Survival Analysis. Statistical methods for analyzing longitudinal data on the occurrence of events. Events may include death, injury, onset of illness,
Introduction to Survival Analysis October 19, 2004 Brian F. Gage, MD, MSc with thanks to Bing Ho, MD, MPH Division of General Medical Sciences.
Growth is the key input in every valuation. Three ways of estimating growth rates: – Historical. While past growth is not always a good indicator of future.
HSRP 734: Advanced Statistical Methods July 24, 2008.
A Brief Overview of Current Research on Dividends Gretchen A. Fix Department of Statistics Rice University 8 October 2003.
Dividend Policies in an Unregulated Market: The London Stock Exchange, Fabio Braggion (Tilburg University & CentER) Lyndon Moore (Victoria University.
April 25 Exam April 27 (bring calculator with exp) Cox-Regression
Terminal Value P.V. Viswanath Valuation of the Firm.
بسم الله الرحمن الرحیم. Generally,survival analysis is a collection of statistical procedures for data analysis for which the outcome variable of.
BIOST 536 Lecture 3 1 Lecture 3 – Overview of study designs Prospective/retrospective  Prospective cohort study: Subjects followed; data collection in.
Chapter 11 Survival Analysis Part 2. 2 Survival Analysis and Regression Combine lots of information Combine lots of information Look at several variables.
Using time-dependent covariates in the Cox model THIS MATERIAL IS NOT REQUIRED FOR YOUR METHODS II EXAM With some examples taken from Fisher and Lin (1999)
Interest Rates and Rates of Return
Main Points to be Covered Cumulative incidence using life table method Difference between cumulative incidence based on proportion of persons at risk and.
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
Survival Analysis for Risk-Ranking of ESP System Performance Teddy Petrou, Rice University August 17, 2005.
Assessing Survival: Cox Proportional Hazards Model Peter T. Donnan Professor of Epidemiology and Biostatistics Statistics for Health Research.
Survival Analysis A Brief Introduction Survival Function, Hazard Function In many medical studies, the primary endpoint is time until an event.
Analysis of Complex Survey Data
Survival Analysis: From Square One to Square Two
Survival analysis Brian Healy, PhD. Previous classes Regression Regression –Linear regression –Multiple regression –Logistic regression.
Introduction to Survival Analysis August 3 and 5, 2004.
Stock Valuation.
Essentials of survival analysis How to practice evidence based oncology European School of Oncology July 2004 Antwerp, Belgium Dr. Iztok Hozo Professor.
NASSER DAVARZANI DEPARTMENT OF KNOWLEDGE ENGINEERING MAASTRICHT UNIVERSITY, 6200 MAASTRICHT, THE NETHERLANDS 22 OCTOBER 2012 Introduction to Survival Analysis.
HSRP 734: Advanced Statistical Methods July 10, 2008.
On ranking in survival analysis: Bounds on the concordance index
1 Introduction to medical survival analysis John Pearson Biostatistics consultant University of Otago Canterbury 7 October 2008.
Prevalence The presence (proportion) of disease or condition in a population (generally irrespective of the duration of the disease) Prevalence: Quantifies.
Assessing Survival: Cox Proportional Hazards Model
Time-dependent covariates and further remarks on likelihood construction Presenter Li,Yin Nov. 24.
Financial Projections Forecast—Budget—Analyze. Three Methods of Analyzing Financial Statements Vertical analysis Horizontal analysis Ratio analysis.
“Further Modeling Issues in Event History Analysis by Robert E. Wright University of Strathclyde, CEPR-London, IZA-Bonn and Scotecon.
INTRODUCTION TO SURVIVAL ANALYSIS
Chapter 12 Survival Analysis.
01/20151 EPI 5344: Survival Analysis in Epidemiology Survival curve comparison (non-regression methods) March 3, 2015 Dr. N. Birkett, School of Epidemiology,
HSRP 734: Advanced Statistical Methods July 17, 2008.
Introduction to Survival Analysis Utah State University January 28, 2008 Bill Welbourn.
HSRP 734: Advanced Statistical Methods July 31, 2008.
Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients with Locoregional Esophageal Carcinoma, Ursa et al. Statistical Methods:
CREATE Biostatistics Core THRio Statistical Considerations Analysis Plan.
1 THE ROLE OF COVARIATES IN CLINICAL TRIALS ANALYSES Ralph B. D’Agostino, Sr., PhD Boston University FDA ODAC March 13, 2006.
Pro gradu –thesis Tuija Hevonkorpi.  Basic of survival analysis  Weibull model  Frailty models  Accelerated failure time model  Case study.
Censoring an observation of a survival r.v. is censored if we don’t know the survival time exactly. usually there are 3 possible reasons for censoring.
Survival Analysis 1 Always be contented, be grateful, be understanding and be compassionate.
Empirical Likelihood for Right Censored and Left Truncated data Jingyu (Julia) Luan University of Kentucky, Johns Hopkins University March 30, 2004.
Survival Analysis approach in evaluating the efficacy of ARV treatment in HIV patients at the Dr GM Hospital in Tshwane, GP of S. Africa Marcus Motshwane.
01/20151 EPI 5344: Survival Analysis in Epidemiology Actuarial and Kaplan-Meier methods February 24, 2015 Dr. N. Birkett, School of Epidemiology, Public.
01/20151 EPI 5344: Survival Analysis in Epidemiology Cox regression: Introduction March 17, 2015 Dr. N. Birkett, School of Epidemiology, Public Health.
IMPORTANCE OF STATISTICS MR.CHITHRAVEL.V ASST.PROFESSOR ACN.
Biostatistics Case Studies 2007 Peter D. Christenson Biostatistician Session 2: Aging and Survival.
01/20151 EPI 5344: Survival Analysis in Epidemiology Hazard March 3, 2015 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine,
INTRODUCTION TO CLINICAL RESEARCH Survival Analysis – Getting Started Karen Bandeen-Roche, Ph.D. July 20, 2010.
1 Chapter 6 SAMPLE SIZE ISSUES Ref: Lachin, Controlled Clinical Trials 2:93-113, 1981.
02/20161 EPI 5344: Survival Analysis in Epidemiology Hazard March 8, 2016 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine,
Additional Regression techniques Scott Harris October 2009.
EPI 5344: Survival Analysis in Epidemiology Week 6 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine, University of Ottawa 03/2016.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 13: Multiple, Logistic and Proportional Hazards Regression.
03/20161 EPI 5344: Survival Analysis in Epidemiology Estimating S(t) from Cox models March 29, 2016 Dr. N. Birkett, School of Epidemiology, Public Health.
DURATION ANALYSIS Eva Hromádková, Applied Econometrics JEM007, IES Lecture 9.
Survival time treatment effects
April 18 Intro to survival analysis Le 11.1 – 11.2
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
Private Placements, Cash Dividends and Interests Transfer: Empirical Evidence from Chinese Listed Firms Source: International review of economics & finance,
Sample Size and Power Part II
Presentation transcript:

A Brief Overview of Really Current Research on Dividends Gretchen A. Fix Department of Statistics Rice University 6 November 2003

Outline Restatement of problem Fama and French hypothesis Our hypothesis Introduction to survival analysis and tools to be used Kaplan-Meier estimator Cox regression Preliminary results

Restatement of Problem Dividends are important—they are the primary determinant of equity value Papers in the finance literature discuss the changing prevalence of dividends Proportion of dividend paying (industrial) firms has decreased over the past 25 years Real and nominal dividends paid out by industrial firms have increased over this period

Fama and French Hypothesis Proportion of public firms paying dividends 66.5 % in % in 1998 Relevant characteristics of dividend payers Profitability Investment opportunities Size

Fama and French Hypothesis Attribute the decline to Changing characteristics of the population of firms in the market Decreased propensity to pay Make note of the “surge” of new lists that began in 1979 Contributed to changing characteristics

Our Hypothesis A firm can do two things with its earnings: Pay them out to equity holders Reinvest in positive NPV projects As a firm matures, growth opportunities will become limited and it will run out of projects and resort to dividends

Our Hypothesis This adds another characteristic to Fama and French’s list Profitability Investment opportunities Size Maturity Time origin for maturity INCORPORATION By default, age seems to be measured by listing

Our Hypothesis We compare the dividend initiation behavior of new lists from two time periods Group 1: New lists in Group 2: New lists in We model our lifecycle hypothesis using the Cox regression framework Model the hazard of initiating dividends Find that accounting for age in terms of incorporation has significant effects on the model output

Data Structure IncorporationListing Dividend/ Censoring  Three time points of interest: incorporation, listing, dividend/censoring  Status of firm is coded as a “1” if endpoint is dividend initiation and “0” if it is a censoring  Censorings are the result of losing a firm (due to merger or bankruptcy) or failure to initiate dividends over the life of the study (12/31/2002)

Data Structure IncorporationListing Dividend/ Censoring  From incorporation to listing, the firm is technically not at risk of becoming a dividend payer; we only care about dividends paid after a firm lists  This looks like delayed entry into the risk set or left-truncation—but it is not!

Data Structure—Left Truncation ExposureRecruitment Death  Left-truncation is a result of study design  For example, subjects are exposed to a toxin; at some time after exposure, they are recruited into a study focusing on mortality resulting from toxin exposure; any subject who died from toxin exposure prior to recruitment would not be eligible to participate in the study  Subjects are not at risk of an observable death during the interval between exposure and recruitment into the study

Data Structure—Challenges We have identified the interval from incorporation to dividend/censoring as the relevant period to study; however Firms are not technically at risk between incorporation and listing It will be difficult to build models using this interval, since there is no comprehensive database for balance sheet information until after firms list

What is Survival Analysis? “a collection of statistical procedures for data analysis for which the outcome variable of interest is time until an event occurs” Kleinbaum, p. 4 Typical applications Biostatistics—study treatment effects in clinical trials Industrial—study failure behavior of a machine

Typical Characteristic of Survival Analysis Data—Censoring Exact survival time of a subject is unknown Usually occurs at the right side of the follow-up period; but can have left or interval censoring Typical reasons for right censoring: 1. Subject does not experience the event before the study ends 2. Subject is lost to follow up during the study 3. Subject withdraws from the study

Functions of Interest in Survival Analysis Survival/survivor function, S(t) Gives probability that a subject survives longer than specified time t S(t) = P(T > t) = 1 – P(T  t) = 1 – F(t) Properties Non increasing S(0) = 1; at the start of the study, all observations are alive S(  ) = 0; if the study time were increased without limit, eventually there would be no observations left alive

Functions of Interest in Survival Analysis Hazard function, λ(t) λ(t) = lim  t  0 P(t  T < t +  t | T  t) /  t “Instantaneous potential per unit time for the event to occur, given that the individual has survived up to time t” Conditional failure RATE (probability per unit time)

Kaplan-Meier Estimator Method for estimating survival curves; aka The Product Limit Estimator In theory, the survival function is a smooth curve; in practice, it is estimated by a right-continuous step function It can be shown that the K-M estimator is the NPMLE of the survival function when one has censored data

Kaplan-Meier Estimator Let t 1, t 2, … t n be the ordered failure times of the sample D i = number of subjects who fail at time t i N i = number of subjects at risk of failure at t i ; these are the subjects that are alive and under observation just prior to t i.

Cox PH Regression Model λ(t,X) = λ o (t)exp{ß 1 X 1 + ß 2 X ß k X k } Hazard at time t is product of two factors λ o (t), the baseline hazard function (does not depend on X) Exponentiated linear sum of the X i (does not depend on t)

Cox PH Regression Model Popularity of the model Form of the baseline hazard left unspecified—gives robustness Exponentiation ensures that fitted model will always give non-negative estimates of the hazard Although the form of the baseline hazard unspecified, after model fitting, it can be recovered and corresponding survival curves for individual observations can be estimated

Cox PH Regression Model The proportional hazards assumption Ratio of the hazards is constant over time

Extended Cox Regression Model Allows time-varying covariates Previously, covariates were not allowed to depend on time (ensured proportionality of hazards) λ(t,X(t)) = λ o (t)exp{ß 1 X 1 (t) + …+ ß k X k (t)}

Preliminary Analysis Data Dataset consists of approximately 2750 firms that listed in or For each firm we have Years of incorporation, listing, dividend/censoring Covariate data (roa, investment, repurchase activity) for each year post listing Dataset was stratified by exchange (NYSE/AMEX or NASDAQ) and market value (above yearly exchange median or below during year of last contact) All analysis presented here was done on the large- NYSE/AMEX stratum

Preliminary Analysis Data We think the average observation from each period looks something like this: Incorporation Listing Dividend group IncorporationListing Dividend group

Preliminary Analysis Data The length of the interval from incorporation to listing was much longer for the early group firm Equivalently, the early group firm had a greater age at list than the late group firm Market conditions of the 80s and 90s allowed firms to go public relatively early in their lifecycles

Preliminary Analysis Simple Statistics The median age of a firm at dividend initiation (or censoring) is 1 year measured from listing. However, the median age at listing is 22.5 years. The median age of a firm at dividend initiation (or censoring) is 3.5 years measured from listing. However, the median age at listing is 5 years.

Preliminary Analysis Simple Statistics Looking only at the uncensored observations: The median age of a firm at dividend initiation is 1 year measured from listing and 33 years measured from incorporation. The median age of a firm at dividend initiation is 1 year measured from listing and 9 years measured from incorporation.

Preliminary Analysis Kaplan-Meier Estimates

Curves generated using listing as time origin show lower propensity to pay for group Curves generated using incorporation as time origin show higher propensity to pay for group

Preliminary Analysis Kaplan-Meier Estimates Limitation of K-M: non-parametric method; cannot take into account any of the covariates which we think affect dividend initiation Attempt to implement our lifecycle model using the Cox regression framework Model the hazard of initiating dividends

Preliminary Analysis Cox Regression—First Model Try λ(t,X(t)) = λ o (t)exp{ß ROA X ROA (t) + ß INV X INV (t) + [ ß AGE X AGE AT LIST ]+ ß GRP X GRP } X ROA (t)(time varying) return on equity value X INV (t)(time varying) investment value X AGE AT LIST age of firm at listing X GRP group indicator (0 if in group, 1 if in group)

Preliminary Analysis Cox Regression Our hypothesis suggests the following output of the model Positive, significant coefficient for ROA Negative, significant coefficient for INV Negative, significant coefficient for GRPIND when AGEATLIST omitted from model Positive, significant coefficient for AGEATLIST; less negative and/or insignificant coefficient for GRPIND when AGEATLIST included in model

Model with ROA, INV, GRPIND Model with ROA, INV, GRPIND, AGEATLIST Preliminary Analysis Cox Regression—First Model Try

Preliminary Analysis Cox Regression Further tweaks to be made DATA: Truncating the data so that we only try to model dividend initiation up to 25 years post incorporation; (accepting that some firms do not conform to our lifecycle hypothesis) MODEL: Consider industry effects (stratify by SIC code) MODEL: Allow the coefficients for ROA and INV to vary for the two time periods Under this model, are we able to pick up the propensity to pay effect? MODEL: Instead of including AGEATLIST, stratify

Preliminary Analysis Truncated Data Truncating the data at 25 years will have the effect of eliminating firms that did not list within 25 years of incorporation from the model Group 1 originally 170 firms, now 88 firms Group 2 originally 186 firms, now 150 firms

Preliminary Analysis Simple Statistics—Truncated Data

Preliminary Analysis K-M Estimates—Truncated Data

Preliminary Analysis Kaplan-Meier Estimates Curves generated using listing as time origin show lower propensity to pay for group; however, this lower propensity is not as strong as before Previous curves showed an increased propensity to pay from incorporation for the group, these curves show little difference between the groups

Preliminary Analysis Cox Regression—Truncated Data Model with ROA, INV, GRPIND Model with ROA, INV, GRPIND, AGEATLIST

Preliminary Analysis Cox Regression—Interacted Model Model with ROA1, ROA2, INV1, INV2, GRPIND Model with ROA1 -- GRPIND, AGEATLIST